TOPIC:

Rigel's bleeding disorder drug clears first of two 7 years 1 month ago #55474

Jeff
Offline
I am the PDSA web guy, and also help with PDSA's social media accounts, like Facebook, Twitter, Instagram, etc.
Posts: 94
Karma: 1
Thank you received: 28

"The drug, fostamatinib, is being studied to treat chronic immune thrombocytopenia (ITP) in which the immune system attacks and destroys the body's own blood platelets.

About 18 percent of the 76 adult patients who were treated with fostamatinib achieved a stable platelet response in the study, compared with none on placebo.

Patients typically had an increase in platelet counts to a level above 50,000/uL within the initial weeks of treatment."

- From Reuters Health News

READ MORE

Jeff Cooper, PDSA website guy

The following user(s) said Thank You: Channer

Please Log in or Create an account to join the conversation.

Page:
1

Forum

PDSA News & Forum Suggestions

PDSA Announcements

Rigel's bleeding disorder drug clears first of two

IMPORTANT!

The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.

Platelet Disorder Support Association
8751 Brecksville Road, Suite 150, Cleveland, Ohio 44141
Phone: 1-87-PLATELET | 877-528-3538 (toll free) | or 440-746-9003
E-mail: pdsa@pdsa.org

© Copyright 1997 - 2023, Platelet Disorder Support Association. All rights reserved. The Platelet Disorder Support Association is a 501(c)3 organization and donations are tax deductible to the fullest extent allowed by law.

TOPIC:

Rigel's bleeding disorder drug clears first of two 7 years 1 month ago #55474

Donate

About PDSA

Stay Informed

IMPORTANT!